Skip to main content

Search TrendsNew Ads Appearances Podcasts API

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.

GOG GYN-LIVE

InnovaTV 205 GOG-3024/ENGOT-cx8 Publication Podcast

Jun 26, 2026 · 12 min · 10 segments

Speakers: Bradley MonkGuestLeslie RandallHost

Top entities: Bradley J. Monk×17 Pembrolizumab×2 National Comprehensive Cancer Network×3 Bevacizumab×3 Northern Virginia

Hosts & Episode Introduction0:04 – 0:36

Leslie RandallHost

0:04

Hi, I'm Dr. Leslie Randall.

Leslie RandallHost

0:05

I'm a GYN oncologist at the Inova Schar Cancer Center in Northern Virginia.

Leslie RandallHost

0:10

And I'm also the cervical cancer advisor for the GOG Partners.

Leslie RandallHost

0:14

And I'm here today with Dr. Bradley Monk, who is the recent senior author of the GOG 3024 Inova TV 205 Innovative TV205.

Leslie RandallHost

0:27

We can all get these names straight lately with so many great trials in the pipeline.

Leslie RandallHost

0:32

So I'm thrilled to be here with you today.

Leslie RandallHost

0:34

Thanks for joining me to talk about your study.

Read the full transcript.

Create an account to read the whole episode, search across every transcript, and follow the shows you care about.

Sign up Already have an account? Log in

Bradley J. MonkPersonAmerican gynecologist and oncologist
95%17 mentions
PembrolizumabEntityDrug
86%2 mentions
National Comprehensive Cancer NetworkCompanyNon-profit organization
77%3 mentions
BevacizumabEntityMedication
68%3 mentions
Northern VirginiaPlaceRegion in Virginia
59%1 mention
Monomethyl auristatin EEntityDrug
50%1 mention
GodEntitySupreme being
41%1 mention
University of California, IrvineCollege or UniversityLand-grant university in Irvine, California
32%1 mention
BleedingEntity
23%1 mention
GynaecologyEntityProfessional field
14%2 mentions
Common Terminology Criteria for Adverse EventsEntity
5%1 mention

HealthcareHealth
OncologyHealth > Healthcare
Cervical CancerHealth > Healthcare > Oncology
Clinical TrialsHealth > Healthcare > Oncology > Cervical Cancer
ImmunotherapyHealth > Healthcare > Oncology > Cervical Cancer
Health
Drug DevelopmentHealth > Healthcare > Oncology > Cervical Cancer
Combination TherapyHealth > Healthcare > Oncology > Cervical Cancer
Treatment AgentsHealth > Healthcare > Oncology > Cervical Cancer

Hosts & Episode Introduction0:04 – 0:36

Leslie RandallHost

0:04

Hi, I'm Dr. Leslie Randall.

Leslie RandallHost

0:05

I'm a GYN oncologist at the Inova Schar Cancer Center in Northern Virginia.

Leslie RandallHost

0:10

And I'm also the cervical cancer advisor for the GOG Partners.

Leslie RandallHost

0:14

And I'm here today with Dr. Bradley Monk, who is the recent senior author of the GOG 3024 Inova TV 205 Innovative TV205.

Leslie RandallHost

0:27

We can all get these names straight lately with so many great trials in the pipeline.

Leslie RandallHost

0:32

So I'm thrilled to be here with you today.

Leslie RandallHost

0:34

Thanks for joining me to talk about your study.